Criterion | Evidence |
Strength of association | Strong association depicted in the study by Corrales-Medina et al. [96] Patients were eight times more likely than controls to have a cardiac event 15 days after hospital admission with CAP |
Consistency of results in a variety of settings | Studies in both primary and secondary care of a variety of study designs, including case–control and cohort, have shown an increased risk of cardiovascular events following acute respiratory infection |
Specificity | Both pneumonia and cardiovascular disease are multifactorial and share common risk factors; therefore, this is difficult to confirm |
Temporality | Primary care database studies showed risk of myocardial infarction decreasing with time following infection [82–84] |
Biological gradient | In the study by Ramirez et al. [94], a positive association between pneumonia severity score and AMI was noted |
Plausibility | Experimental evidence, as highlighted in this review, supports a role for infection in cardiovascular events |
Coherence | Laboratory, epidemiological and clinical evidence is consistent in supporting a role for infection in cardiovascular events |
Experimental evidence | In vitro/animal model studies specific to pneumonia are awaited Vaccination studies to date are not consistent enough to satisfy this criterion [101–104] |
Analogy | The effect of other established cardiovascular risk factors could be considered analogous to that of pneumonia |
CAP: community-acquired pneumonia; AMI: acute myocardial infarction.